Table 2 Three-monthly median taking adherence (MEMS) by time across groups.

From: Improving medication adherence in adult kidney transplantation (IMAKT): A pilot randomised controlled trial

Endpoint

Control

Intervention

Taking adherence

n (%N)

Median (%)*

IQR

n (%N)

Median (%)*

IQR

0–12 months

33 (92)

92.6

59.5, 96.1

31 (89)

89.5

47.7, 98.5

3 months

33 (92)

93.5

83.8, 98.4

31 (89)

95.3

87.0, 98.9

6 months

33 (92)

94.6

67.4, 98.9

31 (89)

93.4

70.3, 100.0

9 months

32 (89)

92.7

38.3, 97.8

31 (89)

91.6

31.0, 98.9

12 months

31 (86)

90.2

16.5, 97.6

29 (83)

78.3

13.5, 97.8

  1. *Data are displayed as the median of the percentage of taking adherence. For each individual, quarterly taking adherence was calculated using this formula:
  2. \({\rm{ \% }}\,{\rm{T}}{\rm{a}}{\rm{k}}{\rm{i}}{\rm{n}}{\rm{g}}\,{\rm{A}}{\rm{d}}{\rm{h}}{\rm{e}}{\rm{r}}{\rm{e}}{\rm{n}}{\rm{c}}{\rm{e}}=\,\frac{{\rm{T}}{\rm{h}}{\rm{e}}\,{\rm{n}}{\rm{u}}{\rm{m}}{\rm{b}}{\rm{e}}{\rm{r}}\,{\rm{o}}{\rm{f}}\,{\rm{d}}{\rm{a}}{\rm{y}}{\rm{s}}\,{\rm{w}}{\rm{i}}{\rm{t}}{\rm{h}}\,{\rm{t}}{\rm{h}}{\rm{e}}\,{\rm{c}}{\rm{o}}{\rm{r}}{\rm{r}}{\rm{e}}{\rm{c}}{\rm{t}}\,{\rm{n}}{\rm{u}}{\rm{m}}{\rm{b}}{\rm{e}}{\rm{r}}\,{\rm{o}}{\rm{f}}\,{\rm{M}}{\rm{E}}{\rm{M}}{\rm{S}}\,{\rm{o}}{\rm{p}}{\rm{e}}{\rm{n}}{\rm{i}}{\rm{n}}{\rm{g}}}{{\rm{T}}{\rm{h}}{\rm{e}}\,{\rm{t}}{\rm{o}}{\rm{t}}{\rm{a}}{\rm{l}}\,{\rm{n}}{\rm{u}}{\rm{m}}{\rm{b}}{\rm{e}}{\rm{r}}\,{\rm{o}}{\rm{f}}\,{\rm{m}}{\rm{o}}{\rm{n}}{\rm{i}}{\rm{t}}{\rm{o}}{\rm{r}}{\rm{e}}{\rm{d}}\,{\rm{d}}{\rm{a}}{\rm{y}}{\rm{s}}}\times 100\).